Nantes, France

Gwennan Andre

This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire De Nantes, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gwennan Andre: Innovator in Bronchodilation

Introduction

Gwennan Andre is a notable inventor based in Nantes, France. She has made significant contributions to the field of medicine, particularly in the development of treatments for respiratory conditions. Her innovative work focuses on the use of Rac1 inhibitors for inducing bronchodilation, which is crucial for patients suffering from airway constriction.

Latest Patents

Gwennan Andre holds a patent for "RAC1 inhibitors for inducing bronchodilation." This invention relates to a Rac1 inhibitor that can be used as a bronchodilator in patients who require such treatment. The patent outlines methods for inducing bronchodilation and reducing airway hyper-responsiveness (AHR) in patients in need.

Career Highlights

Throughout her career, Gwennan has worked with prestigious institutions such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique. Her experience in these organizations has allowed her to advance her research and contribute to significant medical innovations.

Collaborations

Gwennan has collaborated with esteemed colleagues, including Vincent Sauzeau and Gervaise Loirand. These partnerships have enriched her research and expanded the impact of her inventions in the medical community.

Conclusion

Gwennan Andre's work in developing Rac1 inhibitors represents a significant advancement in the treatment of respiratory conditions. Her contributions to medical research and innovation continue to benefit patients in need of effective bronchodilation therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…